CTRI/2018/02/012043尚未招募4 期
Comparision of Efficacy of Ormeloxifene and Tamoxifen in the treatment of cyclical Mastalgia: : A five armed Double Blinded Randomised Controlled Trail
HLL lifecare Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women with regular menstrual cycle having mastalgia with VAS score greater than or equal to 3 lasting for more than 7 days per cycle
排除标准
- •Musculoskeletal or chest wall pain
- •Past history or family history of breast carcinoma
- •Patients with polycystic ovarian diseases and uterine cervical hyperplasia
- •Patients with breast lump or mammary ductal disease
- •First 6 months of lactation
- •Patients who are planning to conceive within the study period
研究者
相似试验
尚未招募
不适用
Comparing Ormeloxifene With Norethisterone In Treatment For Uterine Bleeding Without Any Organic CauseCTRI/2020/06/025630Dr Manogna Chukka
尚未招募
4 期
Comparative Study Between Ormeloxifene And Norethisterone In The Management Of Patients Having Dysfunctional Uterine Bleeding : Prospective Randomized StudyCTRI/2019/08/020648Shri Sathya Sai Medical College And Research Institute
已完成
3 期
Efficacy of ormeloxifene in uterine fibroids compared to oral contraceptivesCTRI/2015/10/006289All India institute of medical Sciences New Delhi50
尚未招募
Unknown
Comparison of Ormeloxifene versus Tranexamic acid in the management of abnormal uterine bleeding in reproductive age group women - a randomized control trialCTRI/2023/04/051568INDIRA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE
尚未招募
不适用
Ormeloxifene: a better therapeutic option than Medroxyprogesterone Acetate in perimenopausal women with abnormal uterine bleeding.CTRI/2019/09/021275ivedita Chawla